Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHS-0214 vs Enbrel in Rheumatoid Arthritis
NCT02115750Phase 3Completed
- Sponsor
- Coherus BioSciences, Inc.
- Start
- May 2014
- Primary completion
- Oct 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 12
01
Overview
A Phase 3 trial of GP2015 in rheumatoid arthritis (RA), sponsored by Coherus BioSciences, Inc.. Started May 2014; status: completed.
02
Drugs
GP2015
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02115750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115750.